1. Incidence and delay of atrial tachycardia after patent foramen ovale closure. (25th November 2020) Authors: Guedeney, P; Silvain, J; Hauguel-Moreau, M; Sabben, C; Deltour, S; Zeitouni, M; Reibel, I; Ferrante, A; Alamowitch, S; Gandjbackch, E; Hidden Lucet, F; Hammoudi, N; Montalescot, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Issue 12 (December 2018) Authors: Kasner, Scott E; Swaminathan, Balakumar; Lavados, Pablo; Sharma, Mukul; Muir, Keith; Veltkamp, Roland; Ameriso, Sebastian F; Endres, Matthias; Lutsep, Helmi; Messé, Steven R; Spence, J David; Nedeltechev, Krassen; Perera, Kanjana; Santo, Gustavo; Olavarria, Veronica; Lindgren, Arne; Bangdiwala, S... Journal: Lancet neurology Issue: Volume 17:Issue 12(2018) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Supraventricular arrhythmia following patent foramen ovale percutaneous closure. (3rd October 2022) Authors: Guedeney, P; Laredo, M; Zeitouni, M; Hauguel-Moreau, M; Wallet, T; Alamowitch, S; Sabben, C; Deltour, S; Benyounes, N; Obadia, M; Collet, J P; Rouanet, S; Hammoudi, N; Silvain, J; Montalescot, G Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗